Benchmark upgraded Repligen rating to buy, while Jefferies Financial Group reaffirmed a hold rating on the company.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Benchmark upgraded Repligen rating to buy, while Jefferies Financial Group reaffirmed a hold rating on the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Repligen
bioTech Company
Nothing else this week.
-
Benchmark
venture capital firm
Nothing else this week.
-
Jefferies Financial Group
American financial services company
Nothing else this week.
Related events
- Jefferies reaffirmed a 'hold' rating on monday.com Ltd. on October 22, 2026.
- Jefferies Financial Group reiterated a buy rating on Constellation Software stock.
- Jefferies Financial Group reissued a 'hold' rating on HarbourVest Global Private Equity shares.
- Jefferies Financial Group lowered its stock rating for Siemens from buy to hold.
- MarketBeat reported the stock's average rating as Benchmark and Jefferies reiterated buy ratings for Bright Minds Biosciences Inc.